These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32605642)

  • 21. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study.
    Cho YK; Kang YM; Yoo JH; Lee J; Park JY; Lee WJ; Kim YJ; Jung CH
    Metabolism; 2019 Aug; 97():50-56. PubMed ID: 31071310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
    Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
    J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Liver Int; 2019 Oct; 39(10):1884-1894. PubMed ID: 31226232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat.
    Chen TP; Lin WY; Chiang CH; Shen TH; Huang KC; Yang KC
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2903-2910. PubMed ID: 33973273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.
    Wu LM; He H; Chen G; Kuang Y; Lin BY; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):252-257. PubMed ID: 32205038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study.
    Yu C; He S; Kuang M; Wang C; Huang X; Sheng G; Zou Y
    BMC Endocr Disord; 2024 Feb; 24(1):22. PubMed ID: 38369482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka.
    Niriella MA; Kasturiratne A; Pathmeswaran A; De Silva ST; Perera KR; Subasinghe SKCE; Kodisinghe SK; Piyaratna TACL; Vithiya K; Dassanayaka AS; De Silva AP; Wickramasinghe AR; Takeuchi F; Kato N; de Silva HJ
    Hepatol Int; 2019 May; 13(3):314-322. PubMed ID: 30539516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome.
    Suárez-Cuenca JA; Domínguez-Pérez GA; Hernández-Muñóz RE; Hernández-Patricio A; Vera-Gómez E; Gutiérrez-Buendía JA; Salamanca-García M; Montoya-Ramírez J; Gaytán-Fuentes OF; Aranda-Rodríguez C; Rojas-Noverón AR; García S; Mondragón-Terán P
    Metab Syndr Relat Disord; 2023 Mar; 21(2):115-121. PubMed ID: 36787445
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
    J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes.
    Hu C; Zhang Y; Wang S; Lin L; Peng K; Du R; Qi H; Zhang J; Wang T; Zhao Z; Li M; Xu Y; Xu M; Li D; Bi Y; Wang W; Chen Y; Lu J
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3322. PubMed ID: 32268002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
    Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
    Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
    Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
    Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.
    Xu Y; Li H; Wang A; Su Z; Yang G; Luo Y; Tao L; Chen S; Wu S; Wang Y; Guo X
    Eur J Endocrinol; 2018 Dec; 179(6):343-352. PubMed ID: 30400019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term metabolic risk for the metabolically healthy overweight/obese phenotype.
    Espinosa De Ycaza AE; Donegan D; Jensen MD
    Int J Obes (Lond); 2018 Mar; 42(3):302-309. PubMed ID: 29064474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.